Insights

Global Clinical Trials CellCarta's extensive network of facilities across Canada, the US, Belgium, Australia, and China positions it strongly to support multinational clinical trials, presenting opportunities to offer tailored testing services and integrated biomarker solutions to multinational pharma and biotech clients.

Advanced Technology Adoption With recent collaborations integrating AI, NGS proteomics kits like Olink Reveal, and proprietary digital pathology platforms, CellCarta is equipped to enhance biomarker discovery and diagnostics, making it an ideal partner for companies seeking cutting-edge technology for personalized medicine developments.

Strategic Partnerships Ongoing collaborations with key industry players such as Leinco Technologies, Pillar Biosciences, and Lunit signify a proactive approach to expanding service offerings and niche capabilities, indicating opportunities to cross-sell services in proteomics, tumor profiling, and AI-powered diagnostics.

Regulatory-Ready Infrastructure With certifications including CAP, CLIA, ISO15189, ISO27001, and ISO13485, CellCarta can confidently serve clients with high regulatory standards, appealing to pharmaceutical companies and diagnostic firms seeking compliant testing and assay development for global markets.

Leadership & Innovation The appointment of a Chief Medical Officer and the launch of platforms like the Kit Inventory Portal reflect a focus on leadership-driven innovation and operational efficiency, creating opportunities to partner with companies aiming to streamline biosample management and enhance clinical trial workflows.

CellCarta Tech Stack

CellCarta uses 8 technology products and services including JazzHR, SQL, oEmbed, and more. Explore CellCarta's tech stack below.

  • JazzHR
    Applicant Tracking Systems
  • SQL
    Database
  • oEmbed
    Dev Tools
  • Microsoft Excel
    Editors
  • Google Fonts API
    Font Scripts
  • ZoomInfo
    Lead Generation
  • Google Tag Manager
    Tag Management
  • TablePress
    Web Platform Extensions

Media & News

CellCarta's Email Address Formats

CellCarta uses at least 1 format(s):
CellCarta Email FormatsExamplePercentage
First.Last@cellcarta.comJohn.Doe@cellcarta.com
90%
FLast@cellcarta.comJDoe@cellcarta.com
5%
First.MiddleLast@cellcarta.comJohn.MichaelDoe@cellcarta.com
4%
FirstLast@cellcarta.comJohnDoe@cellcarta.com
1%

Frequently Asked Questions

Where is CellCarta's headquarters located?

Minus sign iconPlus sign icon
CellCarta's main headquarters is located at 141 Avenue du Président-kennedy Montreal, Quebec h2x 1y4 Canada. The company has employees across 5 continents, including North AmericaEuropeOceania.

What is CellCarta's official website and social media links?

Minus sign iconPlus sign icon
CellCarta's official website is cellcarta.com and has social profiles on LinkedIn.

What is CellCarta's SIC code NAICS code?

Minus sign iconPlus sign icon
CellCarta's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CellCarta have currently?

Minus sign iconPlus sign icon
As of May 2026, CellCarta has approximately 746 employees across 5 continents, including North AmericaEuropeOceania. Key team members include Chief Financial Officer: E. M.Chief Medical Officer & Head Of Companion Diagnostics: E. E.Chief Information Officer: L. N.. Explore CellCarta's employee directory with LeadIQ.

What industry does CellCarta belong to?

Minus sign iconPlus sign icon
CellCarta operates in the Biotechnology Research industry.

What technology does CellCarta use?

Minus sign iconPlus sign icon
CellCarta's tech stack includes JazzHRSQLoEmbedMicrosoft ExcelGoogle Fonts APIZoomInfoGoogle Tag ManagerTablePress.

What is CellCarta's email format?

Minus sign iconPlus sign icon
CellCarta's email format typically follows the pattern of First.Last@cellcarta.com. Find more CellCarta email formats with LeadIQ.

When was CellCarta founded?

Minus sign iconPlus sign icon
CellCarta was founded in 2000.

CellCarta

Biotechnology ResearchQuebec, Canada501-1000 Employees

As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. 

CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services.

At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications.


Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, including CAP, CLIA, ISO15189, ISO27001 and ISO13485.

Section iconCompany Overview

Headquarters
141 Avenue du Président-kennedy Montreal, Quebec h2x 1y4 Canada
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
501-1000

Section iconFunding & Financials

  • $100M$250M

    CellCarta's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    CellCarta's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.